.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Merck
AstraZeneca
Novartis
Chinese Patent Office
Fuji
UBS
Harvard Business School
Queensland Health
Deloitte

Generated: September 19, 2017

DrugPatentWatch Database Preview

Alosetron hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for alosetron hydrochloride and what is the scope of alosetron hydrochloride freedom to operate?

Alosetron hydrochloride
is the generic ingredient in two branded drugs marketed by Sebela Ireland Ltd, Amneal Pharms, and West-ward Pharms Int, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for alosetron hydrochloride. Six suppliers are listed for this compound.

Summary for Generic Name: alosetron hydrochloride

Tradenames:2
Patents:0
Applicants:3
NDAs:3
Drug Master File Entries: see list3
Suppliers / Packagers: see list6
Bulk Api Vendors: see list50
Clinical Trials: see list2,272
Patent Applications: see list228
Therapeutic Class:Gastrointestinal Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:alosetron hydrochloride at DailyMed

Pharmacology for Ingredient: alosetron hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sebela Ireland Ltd
LOTRONEX
alosetron hydrochloride
TABLET;ORAL021107-001Feb 9, 2000ABRXYesYes► Subscribe► Subscribe► Subscribe
West-ward Pharms Int
ALOSETRON HYDROCHLORIDE
alosetron hydrochloride
TABLET;ORAL200652-002May 4, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Sebela Ireland Ltd
LOTRONEX
alosetron hydrochloride
TABLET;ORAL021107-002Dec 23, 2003ABRXYesNo► Subscribe► Subscribe► Subscribe
Amneal Pharms
ALOSETRON HYDROCHLORIDE
alosetron hydrochloride
TABLET;ORAL206647-002Dec 22, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Amneal Pharms
ALOSETRON HYDROCHLORIDE
alosetron hydrochloride
TABLET;ORAL206647-001Dec 22, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
West-ward Pharms Int
ALOSETRON HYDROCHLORIDE
alosetron hydrochloride
TABLET;ORAL200652-001May 4, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: alosetron hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sebela Ireland Ltd
LOTRONEX
alosetron hydrochloride
TABLET;ORAL021107-002Dec 23, 2003► Subscribe► Subscribe
Sebela Ireland Ltd
LOTRONEX
alosetron hydrochloride
TABLET;ORAL021107-001Feb 9, 2000► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Accenture
Fuji
Federal Trade Commission
Deloitte
UBS
Argus Health
Merck
Daiichi Sankyo
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot